Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Tumour removal

E. coll) Ingelheim subsequent tumour removal, to prevent or delay amputation ... [Pg.507]

If a (3-adrenoceptor antagonist is administered prior to sufficient ol-radrenoceptor blockade, a hypertensive episode may be precipitated with cardiac failure and pulmonary oedema. Most intravenous anaesthetic agents have been used safely, but ketamine is contraindicated. Sodium nitroprusside can be used to achieve arteriolar dilation. Esmolol, a pi-selective antagonist with very short duration of action, is administered intravenously to prevent cardiac arrhythmias intra-operatively. After tumour removal, volume administration should be aggressive to maintain haemodynamic stability, and a noradrenaline infusion may be required. [Pg.218]

Elevated serum copper levels were also found in dogs with radiation-induced and spontaneous osteosarcoma [353]. No clinical signs of metastasis were observed following tumour removal, by limb amputation, and there was a return to normal or near-normal serum copper levels. Dogs with nonmalig-nant nonosteosarcoma lesions were found to have normal serum copper levels. Detailed studies of altered copper metabolism in tumour-bearing mice and rats have also been recently reviewed [354]. [Pg.504]

Over the past two decades, HA has become the most extensively used material in plastic surgery, ophthalmology and orthopaedics. The use of HA in reconstructive surgery, as a dermal filler, dressing, or cream, centres on the restoration of soft tissue defects, and the treatment of wounds and burns. Typically, these defects are secondary to surgical or physical trauma, especially in subtractive surgeries, such as tumour removal. HA is used as a filler due to its ability not only to restore the lost volume, but to also improve the quality of the skin, namely its elasticity, plasticity and hydration. [Pg.140]

C2-3 destruction VA displaced tumour stain CSF space no compression no tumour removal excellent 5 years, then died from other causes... [Pg.149]

C2-4 destruction not done CSF space com- destruction and tumour removal excellent for 3 years... [Pg.149]

X 20 mm soft-tissue shadow vascular- ized tumour in meso- pharynx not done not done tumour removal excellent 3 years... [Pg.151]

IL-2-stimulated cytotoxic T cells appear even more efficacious than LAK cells in promoting tumour regression. The approach adopted here entails removal of a tumour biopsy, followed by isolation of T-lymphocytes present within the tumour. These tumour-infiltrating lymphocytes (TILs) are cytotoxic T-lymphocytes that apparently display a cell surface receptor which specifically binds the tumour antigen in question. They are thus tumour-specific cells. Further activation of these TILs by in vitro culturing in the presence of IL-2, followed by reintroduction into the patient along with IL-2, promoted partial/full tumour regression in well over 50 per cent of treated patients. [Pg.248]

Adrenal Tumours The assay-method is entirely based on the Schwartz-Mann Kit. According to this method, cortisol is first extracted from the plasma using CH2C12 (methylene chloride). In the actual radioimmunoassay the cortisol present in the extract competes with Cortisol-H3 i.e., the radioactive tracer) for the common binding sites on transcortin, which is incidently not an antibody but a cortisol-binding protein. Now, the free cortisol is quantitatively removed by adsorption on dextran-coated charcoal from the one bound to the transcortin. Finally, the bound radioactivity (due to Cortisol-H3) is measured which is then employed to calculate exactly the amount of cortisol present in the sample by the help of a Standard Curve (or Calibration Curve). [Pg.64]

Benign tnmonrs are nsnally only a problem when they impair the fnnction of organs or canse metabolic stress. They can be removed by snrgery or radiation therapy. Malignant tnmonrs are mnch more of a problem, since the cells can escape from the primary tnmonr to other sites in the body, where they settle and develop into secondary tumours (metastases). Then, chemotherapy is the only treatment available. The process is known as metastasis. [Pg.495]

Radiotherapy is the use of ionising radiation to damage and kill tumour cells. Radical radiotherapy involves using radiotherapy to cure the tumour. It may be combined with chemotherapy before, during or after radiotherapy. Adjuvant radiotherapy, for example following surgery to remove a tumour, is given to eradicate residual tumour... [Pg.507]

Kupffer cells are the largest reservoir of fixed-tissue macrophages and are quantitatively the most important cell type for the removal of circulating microorganisms, EPS, tumour cells. [Pg.93]

Figure 9.3. Photograph of a mouse 7 days after i.v. injection of a coaguligand formulation consisting of truncated Tissue Factor mixed with a bispecific antibody directed at the MHC Class II molecules on the tumour vasculature and at truncated Tissue Factor. The mouse carried a C1300 muy tumour measuring approximately 10 x 10 mm in diameter at the time of treatment. Within hours after treatment the tumour blood flow was blocked by generalized blood coagulation in the tumour vasculature (not shown). Seven days after treatment, the necrotic tissue was almost completely removed by the host immune cells. Figure 9.3. Photograph of a mouse 7 days after i.v. injection of a coaguligand formulation consisting of truncated Tissue Factor mixed with a bispecific antibody directed at the MHC Class II molecules on the tumour vasculature and at truncated Tissue Factor. The mouse carried a C1300 muy tumour measuring approximately 10 x 10 mm in diameter at the time of treatment. Within hours after treatment the tumour blood flow was blocked by generalized blood coagulation in the tumour vasculature (not shown). Seven days after treatment, the necrotic tissue was almost completely removed by the host immune cells.
Fig. 14 ZK-253 effects on tamoxifen-resistant breast cancer xenograft tumours. Estrogen-dependent MCF-7/TAM tumours were implanted on day 0 into one flank of 70 estrogen-and tamoxifen-supplemented nude mice. After tumours had reached approximately 25 mm in size (after about 22 days), mice were randomised into seven groups (10 mice each) three control groups (control tamoxifen, control vehicle or control ovariectomy without estradiol), and the fom treatment groups (ZK-703, ZK-253, raloxifene or fulves-trant) each at 10 mg/kg subcutaneously daily. Treatment was continued either until the end of the experiment or imtil tumoms reached a median of approximately 100 mm (larger tumours were observed in some mice). The tumours were then removed, snap frozen, and used for analysis of ER levels, a Xenograft tumour growth curves. Data are expressed as medians with interquartile ranges, b ERa levels. Data are expressed as mean with upper 95% Cl... Fig. 14 ZK-253 effects on tamoxifen-resistant breast cancer xenograft tumours. Estrogen-dependent MCF-7/TAM tumours were implanted on day 0 into one flank of 70 estrogen-and tamoxifen-supplemented nude mice. After tumours had reached approximately 25 mm in size (after about 22 days), mice were randomised into seven groups (10 mice each) three control groups (control tamoxifen, control vehicle or control ovariectomy without estradiol), and the fom treatment groups (ZK-703, ZK-253, raloxifene or fulves-trant) each at 10 mg/kg subcutaneously daily. Treatment was continued either until the end of the experiment or imtil tumoms reached a median of approximately 100 mm (larger tumours were observed in some mice). The tumours were then removed, snap frozen, and used for analysis of ER levels, a Xenograft tumour growth curves. Data are expressed as medians with interquartile ranges, b ERa levels. Data are expressed as mean with upper 95% Cl...
Therapy in those with ectopic erythropoietin production depends upon correcting the hormone level by removing whatever tissue is responsible for its production and examples include nephrectomy for renal carcinoma or the classical, albeit rare, cerebellar haemangioblastoma. Where metastases have occurred appropriate cytotoxic chemotherapy is needed and response in haematocrit becomes a rough indicator of the success with which the tumour is responding to therapy. In some individuals venesections are necessary to control the raised haemoglobin. [Pg.738]

Cushing s disease (caused by a pituitary ACTH-secreting adenoma) or Cushing s syndrome from an adrenal tumour is normally treated by surgical removal of the primary lesion where possible. Cases of ectopic ACTH syndrome associated with carcinoma of the bronchus cannot be treated surgically, and often benefit from medical therapy to control adrenal steroid excess. [Pg.775]

Noradrenaline is used to treat shock-like conditions associated with peripheral vasodilatation, e.g. sepsis, systemic inflammatory response syndrome (SIRS), neurogenic shock. The rationale of its use in sepsis and SIRS is to counteract the vasodilatory effects of nitric oxide. Following the surgical removal of phaeochromocytoma and similar tumours, noradrenaline is often given to maintain blood pressure in the initial period. During and after cardiac surgery, it may be used to optimise haemodynamic parameters in combination with other drugs, such as phosphodi-esterase inhibitors. Dose... [Pg.152]


See other pages where Tumour removal is mentioned: [Pg.487]    [Pg.300]    [Pg.149]    [Pg.149]    [Pg.149]    [Pg.151]    [Pg.151]    [Pg.487]    [Pg.300]    [Pg.149]    [Pg.149]    [Pg.149]    [Pg.151]    [Pg.151]    [Pg.138]    [Pg.476]    [Pg.8]    [Pg.52]    [Pg.185]    [Pg.238]    [Pg.1186]    [Pg.124]    [Pg.140]    [Pg.127]    [Pg.479]    [Pg.486]    [Pg.199]    [Pg.202]    [Pg.249]    [Pg.291]    [Pg.353]    [Pg.65]    [Pg.16]    [Pg.252]    [Pg.423]    [Pg.486]    [Pg.454]    [Pg.118]    [Pg.224]    [Pg.141]   
See also in sourсe #XX -- [ Pg.140 ]




SEARCH



© 2024 chempedia.info